Genetic polymorphisms in several folate enzymes, most notably methylenetetrahydrofolate reductase (MTHFR), have also been associated with increased risk of several cancers [6,7,8], underscoring the role of folate metabolism in tumorigenesis. Here, MTHFR is linked to cancer.